Navigation Links
U.S. Government Awards DuPont, Partners with Technology Investment Agreement for Macroalgae-to-Biobutanol Research
Date:3/2/2010

Next-Generation Biofuels Awarded $17.7 Million by U.S. Department of Energy

Wilmington, Del. (Vocus) March 2, 2010 -- The U.S. Department of Energy (DOE) Advanced Research Projects Agency-Energy (ARPA-E) has awarded a Technology Investment Agreement to DuPont for the development of a process to convert sugars produced by macroalgae into next-generation biofuels called isobutanol. Bio Architecture Lab (BAL) will be a subrecipient on the program. Under this award, the DOE will fund $8.8 million and DuPont and BAL will cost share the balance of the total award, forming a joint cost share program between DOE and DuPont. Butamax™ Advanced Biofuels LLC, a joint venture between DuPont and BP, will be responsible for commercialization of the resulting technology package.

The macroalgae-to-isobutanol project will establish technology and intellectual property leadership in the use of macroalgae as a low cost, scalable and environmentally sustainable biomass for biofuel production. Efforts will focus on: improving domestic macroalgae aquaculture; converting macroalgae to bio-available sugars; converting those sugars to isobutanol; and economic and environmental optimization of the production process. More than 60 scientists in Wilmington, Del., and Berkeley, Calif., will work on this research and development program. The macroalgae aquafarming project will be conducted in Southern California.

“Our capabilities in the field of metabolic engineering and advanced industrial biotechnology techniques make this a natural addition to our existing R&D pipeline,” said John Pierce, vice president – DuPont Applied BioSciences - Technology.

“Bio Architecture Lab is the leader in the development of technology to utilize macroalgae as low cost, scalable and sustainable biomass for the production of biofuels,” said Nikesh Parekh, CEO of Bio Architecture Lab. “Our partnership with DuPont and Butamax™ validates our core technology and will help us extend it into the production of isobutanol.”

Butamax™ has a multi-generational program to introduce isobutanol from different feedstocks to the market. Initially, isobutanol will be produced from feedstocks such as corn, wheat, and sugarcane. Subsequently, isobutanol production can be based on cellulosic feedstocks and, eventually, advanced feedstocks such as macroalgae.

“We project macroalgae to biobutanol technology will reduce greenhouse gas emissions significantly compared to petroleum,” said Butamax™ CEO Tim Potter. “Butamax™ is expanding its feedstock flexibility to deliver isobutanol sustainably to achieve ever-cleaner transportation fuels. This evolutionary feedstock approach will enable greater reductions in carbon intensity as sustainable lower carbon feedstocks emerge.”

DuPont and BP were the first to identify the potential of isobutanol as an advanced biofuel. Their partnership was formalized in July 2009 with the creation of the Butamax™ Advanced Biofuels LLC joint venture. ButamaxTM and its parent companies have validated the potential of isobutanol to be a viable opportunity to advance biofuels through fleet testing and examination of the fuel value chain.

Butamax™ will commercialize isobutanol, a fuel that:

 
  • has a higher energy content per gallon than many first generation biofuels;
  • does not absorb water and can be transported through the existing oil and gasoline distribution infrastructure;
  • can be used in gasoline-powered vehicles without modification at higher volumes than first generation biofuels, enabling greater concentrations of renewables into the transport fuel mix.
Butamax™ Advanced Biofuels is the culmination of the partnership between DuPont and BP and will be the leader in isobutanol technology development and marketing. The synergy between Butamax™ as a fast moving and flexible commercialization enterprise and the considerable experience of DuPont and BP in the areas of advanced biotechnology development, transportation fuel design and marketing will achieve rapid market acceptance of the technology developed under this award.

Bio Architecture Lab is a pioneer in the application of synthetic biology and enzyme design to the development of biofuels and renewable chemicals from aquafarmed, native macroalgae (seaweed), which is a low cost, scalable and sustainable biomass.

DuPont is a science-based products and services company. Founded in 1802, DuPont puts science to work by creating sustainable solutions essential to a better, safer, healthier life for people everywhere. Operating in more than 70 countries, DuPont offers a wide range of innovative products and services for markets including agriculture and food; building and construction; communications; and transportation.

Forward-Looking Statements: This news release contains forward-looking statements based on management’s current expectations, estimates and projections. The company does not undertake to update any forward-looking statements as a result of future developments or new information. All statements that address expectations or projections about the future, including statements about the company’s strategy for growth, product development, market position, expected expenditures and financial results are forward-looking statements. Some of the forward-looking statements may be identified by words like “expects,” “anticipates,” “plans,” “intends,” “projects,” “indicates,” and similar expressions. These statements are not guarantees of future performance and involve a number of risks, uncertainties and assumptions. Many factors, including those discussed more fully elsewhere in this release and in DuPont’s filings with the Securities and Exchange Commission, particularly its latest annual report on Form 10-K, as well as others, could cause results to differ materially from those stated. These factors include, but are not limited to changes in the laws, regulations, policies and economic conditions of countries in which the company does business; competitive pressures; successful integration of structural changes, including acquisitions, divestitures and alliances; research and development of new products, including regulatory approval and market acceptance, and seasonality of sales of agricultural products.

Contacts:   
Michelle Reardon – DuPont & Butamax™
302-530-9197
michelle.s.reardon(at)usa.dupont(dot)com

John Williams – BAL
206-625-0075
jwilliams(at)scovillepr(dot)com

###

Read the full story at http://www.prweb.com/releases/2010/03/prweb3673864.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Brazilian Sugarcane Industry Association Stresses Need for Brazils Government to Announce Ethanol Import Tariff Cut as Soon as Possible
2. North Carolina-based Cnanoz Unveils NanoPure(TM) to Government Leaders in Hyderabad, India
3. US Government Awards Contract to Bavarian Nordic for the Development of Freeze-Dried IMVAMUNE(R) Smallpox Vaccine
4. Sinovac Obtains Third H1N1 Vaccine Order from Chinese Central Government
5. Sinovac Obtains Initial Order of H1N1 Vaccine from Chinese Central Government
6. BD Announces Flu Product Order from U.S. Government
7. Human Genome Sciences Announces New Order for Raxibacumab (ABthrax(TM)) from U.S. Government
8. Novavax Announces Appointment of John J. Trizzino as Senior Vice President, International and Government Alliances
9. UCR physicist receives highest honor US government gives young scientists or engineers
10. Spanish Government Selects Novavaxs VLP Technology for Comprehensive Flu Vaccine Solution in Spain
11. Government Mandates Create Guaranteed Market for Bio-Fuel, Says Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
U.S. Government Awards DuPont, Partners with Technology Investment Agreement for Macroalgae-to-Biobutanol Research
(Date:6/23/2016)... 23, 2016  Blueprint Bio, a company dedicated to ... medical community, has closed its Series A funding round, ... "We have received a commitment from Forentis ... need to meet our current goals," stated Matthew ... runway to complete validation on the current projects in ...
(Date:6/23/2016)... -- On Wednesday, June 22, 2016, the NASDAQ ... Dow Jones Industrial Average edged 0.27% lower to finish at ... Stock-Callers.com has initiated coverage on the following equities: Infinity Pharmaceuticals ... NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ ... Learn more about these stocks by accessing their free trade ...
(Date:6/23/2016)... ... 23, 2016 , ... Regulatory Compliance Associates® Inc. (RCA), a ... webinar on Performing Quality Investigations: Getting to Root Cause. This ... charge. , Incomplete investigations are still a major concern to the Regulatory Authorities ...
(Date:6/23/2016)... June 22, 2016  Amgen (NASDAQ: AMGN ... QB3@953 life sciences incubator to accelerate the ... shared laboratory space at QB3@953 was created to help ... obstacle for many early stage organizations - access to ... sponsorship, Amgen launched two "Amgen Golden Ticket" awards, providing ...
Breaking Biology Technology:
(Date:4/28/2016)... April 28, 2016 First quarter 2016:   ... 966% compared with the first quarter of 2015 The ... 589.1 M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) ... guidance is unchanged, SEK 7,000-8,500 M. The operating margin ...
(Date:4/15/2016)... , April 15, 2016 ... the,  "Global Gait Biometrics Market 2016-2020,"  report to ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,The global gait biometrics ... of 13.98% during the period 2016-2020. ... angles, which can be used to compute factors ...
(Date:3/29/2016)... March 29, 2016 LegacyXChange, Inc. ... "LEGX" and SelectaDNA/CSI Protect are pleased to announce our ... in a variety of writing instruments, ensuring athletes signatures ... created collectibles from athletes on LegacyXChange will be assured ... the DNA. Bill Bollander , CEO ...
Breaking Biology News(10 mins):